Class II · Moderate riskTerminated Initiated Apr 13, 2022 (4 years ago)
Cefazolin for injection USP, and Dextrose Injection, USP, 2 g, 50 mL duplex container, Rx…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
cGMP deviations: Temperature abuse
What was recalled
Cefazolin for injection USP, and Dextrose Injection, USP, 2 g, 50 mL duplex container, Rx only, MFG: B. Braun Medical Inc., NDC 0264-3105-11
Recalling firm
Mckesson Medical-Surgical Inc. Corporate Office
NDC code
0264-3105-11
Origin
VA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1118-2022
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason Labeling: Label Mix-Up; cartons of Cefazolin for Injection, USP 1 gram were found to contain vials labeled as penicillin G potassium for Injection…